Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Soc Rev ; 47(14): 5312-5337, 2018 Jul 17.
Article in English | MEDLINE | ID: mdl-29770369

ABSTRACT

The applications of nanoparticles (NPs) are increasing exponentially in consumer products, biotechnology and biomedicine, and humans, as well as the environment, are increasingly being exposed to NPs. Analogously, various (pathogenic) microorganisms are present at all the major exposure and entry sites for NPs in the human body as well as in environmental habitats. However, the field has just started to explore the complex interplay between NPs and microbes and the (patho)biological consequences. Based on recent insights, herein, we critically reviewed the available knowledge about the interaction of NPs with microbes and the analytical investigations including the latest intravital imaging tools. We have commented on how the NPs' characteristics influence complex formation with microorganisms, presented the underlying physicochemical forces, and provided examples of how this knowledge can be used to rationally control the NP-microbe interaction. We concluded by discussing the role of the biomolecule corona in NP-microbe crosstalk and speculated the impact of NP-microbe complex formation on the (patho)biological outcome and fate of microbial pathogens. The presented insights will not only support the field in engineering NPs with improved anti-microbial activity but also stimulate research on the biomedical and toxicological relevance of nanomaterial-microbiome complex formation for the anthropocene in general.


Subject(s)
Gram-Negative Bacteria/metabolism , Gram-Positive Bacteria/metabolism , Nanoparticles/metabolism , Spores, Fungal/metabolism , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Humans , Microalgae/drug effects , Microalgae/metabolism , Nanoparticles/chemistry , Nanoparticles/toxicity , Optical Imaging , Pollen/drug effects , Pollen/metabolism , Spores, Fungal/drug effects
2.
Chem Soc Rev ; 44(17): 6094-121, 2015 Oct 07.
Article in English | MEDLINE | ID: mdl-26065524

ABSTRACT

Besides the wide use of engineered nanomaterials (NMs) in technical products, their applications are not only increasing in biotechnology and biomedicine, but also in the environmental field. While the physico-chemical properties and behaviour of NMs can be characterized accurately under idealized conditions, this is no longer the case in complex physiological or natural environments. Herein, proteins and other biomolecules rapidly bind to NMs, forming a protein/biomolecule corona that critically affects the NMs' (patho)biological and technical identities. As the corona impacts the in vitro and/or in vivo NM applications in humans and ecosystems, a mechanistic understanding of its relevance and of the biophysical forces regulating corona formation is mandatory. Based on recent insights, we here critically review and present an updated concept of corona formation and evolution. We comment on how corona signatures may be linked to effects at the nano-bio interface in physiological and environmental systems. In order to comprehensively analyse corona profiles and to mechanistically understand the coronas' biological/ecological impact, we present a tiered multidisciplinary approach. To stimulate progress in this field, we introduce the potential impact of the corona for NM-microbiome-(human)host interactions and the novel concept of 'nanologicals', i.e., the nanomaterial-specific targeting of molecular machines. We conclude by discussing the relevant challenges that still need to be resolved in this field.


Subject(s)
Nanoparticles/chemistry , Nanoparticles/metabolism , Nanoparticles/toxicity , Proteins/metabolism , Animals , Blood/drug effects , Chemistry Techniques, Analytical/methods , Humans , Hydrogen-Ion Concentration , Kinetics , Lung/physiology , Microbiota , Osmolar Concentration , Proteins/chemistry , Proteins/pharmacokinetics , Toxicity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...